StockWatch
·
Healthcare Research- Analytics & Technology
Board Meeting8 Oct 2026, 06:30 pm

Syngene Board Meeting on Oct 27 to Approve Q2 FY27 Results

AI Summary

Syngene International Ltd has announced that its Board of Directors will convene on October 27, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ending September 30, 2026. The company has also closed its trading window for insiders from October 1, 2026, to October 29, 2026. An investor and analyst conference call is scheduled for October 28, 2026, with details to be provided on the company's website.

Key Highlights

  • Board meeting scheduled for October 27, 2026.
  • To approve un-audited financial results for Q2 FY27.
  • Trading window closed for insiders until October 29, 2026.
  • Conference call for analysts and investors on October 28, 2026.